company background image
BVS logo

Bioventus NasdaqGS:BVS Stock Report

Last Price

US$11.47

Market Cap

US$938.5m

7D

-2.6%

1Y

257.3%

Updated

09 Oct, 2024

Data

Company Financials +

BVS Stock Overview

A medical device company, focuses on developing and commercializing treatments that engage and enhance the body’s natural healing process in the United States and internationally.

BVS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Bioventus Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bioventus
Historical stock prices
Current Share PriceUS$11.47
52 Week HighUS$12.41
52 Week LowUS$2.85
Beta0.90
11 Month Change9.24%
3 Month Change74.32%
1 Year Change257.32%
33 Year Change-17.06%
5 Year Changen/a
Change since IPO-40.29%

Recent News & Updates

Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024

Aug 12

Recent updates

Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024

Aug 12

Bioventus: Bullish On Path To Profitability

Jan 24

Bioventus: Reiterating Buy Thesis Following Q2 Earnings

Sep 08

Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M

Aug 11

Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal

Aug 03

Bioventus: Strong Value Gap, Insulated Via Leading Market Share

Jun 14

Bioventus: Thoughts After An Active First Year

Mar 29

Shareholder Returns

BVSUS Medical EquipmentUS Market
7D-2.6%-0.7%0.6%
1Y257.3%19.4%30.3%

Return vs Industry: BVS exceeded the US Medical Equipment industry which returned 19.4% over the past year.

Return vs Market: BVS exceeded the US Market which returned 30.3% over the past year.

Price Volatility

Is BVS's price volatile compared to industry and market?
BVS volatility
BVS Average Weekly Movement11.9%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.4%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: BVS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: BVS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20111,030Rob Claypoolewww.bioventus.com

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body’s natural healing process in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications.

Bioventus Inc. Fundamentals Summary

How do Bioventus's earnings and revenue compare to its market cap?
BVS fundamental statistics
Market capUS$938.48m
Earnings (TTM)-US$41.96m
Revenue (TTM)US$536.89m

1.4x

P/S Ratio

-17.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BVS income statement (TTM)
RevenueUS$536.89m
Cost of RevenueUS$179.72m
Gross ProfitUS$357.17m
Other ExpensesUS$399.13m
Earnings-US$41.96m

Last Reported Earnings

Jun 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.64
Gross Margin66.53%
Net Profit Margin-7.82%
Debt/Equity Ratio202.7%

How did BVS perform over the long term?

See historical performance and comparison